This review summarizes the role of PSMA targeted diagnosis in PCa diagnosis and its influence on prognosis, providing a new PCa diagnosis idea for clinicians and optimizing the clinical management of PCa patients. The gene discussed is FOLH1; the disease is posterior cortical atrophy.